Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs ...
Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas. The 4-year-old subsidiary of Google ...
Editor’s note: Spike Brehm, the author of this post, is just one of the amazing hackers we’ve got speaking at DevBeat 2013, our first-ever developer conference taking place next week, Nov. 12-13 in ...
Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback